Patent Issued for Compositions and methods for increasing expression of SCN2A (USPTO 11713463).

Keywords: Autism; Developmental Disabilities; Developmental Diseases and Conditions; Genetics; Health and Medicine; Mental Health; Mental Health Diseases and Conditions; Neurology; Neuroscience; The Florey Institute of Neuroscience and Mental Health EN Autism Developmental Disabilities Developmental Diseases and Conditions Genetics Health and Medicine Mental Health Mental Health Diseases and Conditions Neurology Neuroscience The Florey Institute of Neuroscience and Mental Health 2368 2368 1 08/21/23 20230821 NES 230821 2023 AUG 25 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- The Florey Institute of Neuroscience and Mental Health (Parkville, Australia) has been issued patent number 11713463, according to news reporting originating out of Alexandria, Virginia, by NewsRx editors. Autism, Developmental Disabilities, Developmental Diseases and Conditions, Genetics, Health and Medicine, Mental Health, Mental Health Diseases and Conditions, Neurology, Neuroscience, The Florey Institute of Neuroscience and Mental Health. [Extracted from the article]